Eignapharma

Eignapharma is a Barcelona-based pharmaceutical company specializing in the development, licensing, and supply of high-quality generic and value-added medicines. The company focuses on niche and complex products across various therapeutic areas, including oncology, central nervous system, and cardiovascular health. Eignapharma operates primarily through a B2B model, partnering with pharmaceutical companies worldwide to provide finished dosage forms and intellectual property. Their services encompass the entire product lifecycle, from initial R&D and formulation to regulatory filing and commercial supply. By leveraging a global network of manufacturing partners, Eignapharma ensures a reliable supply of essential medications to international markets. The company is particularly known for its expertise in Value Added Medicines (VAMs), which aim to improve patient outcomes through enhanced drug delivery or optimized formulations.